During the past decade, Centre Hospitalier Privé Saint-Grégoire conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 6 clinical trials were completed, i.e. on average, 12.2% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 5 clinical trials were completed. i.e. 20.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Privé Saint-Grégoire" #1 sponsor was "UNICANCER" with 11 trials, followed by "Pfizer" with 5 trials sponsored, "ARCAGY/ GINECO GROUP" with 4 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored and "Federation Francophone de Cancerologie Digestive" with 3 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Privé Saint-Grégoire" #1 collaborator was "Bayer" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator and "GORTEC" with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Privé Saint-Grégoire" are "Prostate Cancer" (5 trials), "Metastatic Breast Cancer" (4 trials), "Breast Cancer" (3 trials), "Colorectal Cancer" (3 trials) and "Metastatic Colorectal Cancer" (3 trials). Many other conditions were trialed in "Centre Hospitalier Privé Saint-Grégoire" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Privé Saint-Grégoire" are "Drug" (45 trials), "Other" (16 trials), "Radiation" (12 trials), "Procedure" (7 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Anastrozole" (3 trials), "Bevacizumab" (3 trials), "Irinotecan" (3 trials) and "Letrozole" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Privé Saint-Grégoire" are 53 trials for "All" genders, 10 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier Privé Saint-Grégoire". undefined are not yet recruiting, 16 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Centre Hospitalier Privé Saint-Grégoire, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Privé Saint-Grégoire, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".

Centre Hospitalier Privé Saint-Grégoire has several departments that took part in Clinical trials: "Chp Saint Gregoire; Cancerologie Radiotherapie" - 7 trials, "Département de Chirurgie Digestive et Hépatobiliaire - Centre Hospitalier Privé Saint Grégoire" - 2 trials